- Home
- QGEN vs PSO Comparison
QGEN vs PSO Comparison
Compare QGEN & PSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- PSO
- Stock Information
- Founded
- QGEN 1986
- PSO 1844
- Country
- QGEN Netherlands
- PSO United Kingdom
- Employees
- QGEN N/A
- PSO N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- PSO Books
- Sector
- QGEN Health Care
- PSO Consumer Discretionary
- Exchange
- QGEN Nasdaq
- PSO Nasdaq
- Market Cap
- QGEN 9.9B
- PSO 9.0B
- IPO Year
- QGEN 1996
- PSO 2000
- Fundamental
- Price
- QGEN $42.68
- PSO $13.60
- Analyst Decision
- QGEN Buy
- PSO
- Analyst Count
- QGEN 10
- PSO 0
- Target Price
- QGEN $50.07
- PSO N/A
- AVG Volume (30 Days)
- QGEN 1.2M
- PSO 283.9K
- Earning Date
- QGEN 11-06-2024
- PSO 01-01-0001
- Dividend Yield
- QGEN 3.09%
- PSO 2.17%
- EPS Growth
- QGEN N/A
- PSO 23.43
- EPS
- QGEN 0.33
- PSO 0.63
- Revenue
- QGEN $1,940,199,000.00
- PSO $4,485,194,688.00
- Revenue This Year
- QGEN $2.68
- PSO N/A
- Revenue Next Year
- QGEN $6.10
- PSO $3.99
- P/E Ratio
- QGEN $132.61
- PSO $20.47
- Revenue Growth
- QGEN N/A
- PSO N/A
- 52 Week Low
- QGEN $34.74
- PSO $10.84
- 52 Week High
- QGEN $47.44
- PSO $14.20
- Technical
- Relative Strength Index (RSI)
- QGEN 37.68
- PSO 54.49
- Support Level
- QGEN $43.69
- PSO $13.29
- Resistance Level
- QGEN $44.61
- PSO $13.56
- Average True Range (ATR)
- QGEN 0.62
- PSO 0.11
- MACD
- QGEN -0.11
- PSO 0.01
- Stochastic Oscillator
- QGEN 12.09
- PSO 90.00
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About PSO Pearson Plc
U.K.-listed Pearson is the world's largest educational provider. The company has been disposing of noncore businesses such as the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider. While Pearson's primary activity centres on higher-level education, the firm also has significant operations in providing clinical assessments, professional certification and testing.